Changes in brain volume in response to estradiol levels, amphetamine sensitization and haloperidol treatment in awake female rats

Brain Research

Volumn 1618, Issue , 2015, Pages 100-110

  Madularu, Dan ^a   Kulkarni, Praveen ^b   Ferris, Craig F ^b   Brake, Wayne G ^a  

^a McGill University ^*  (Canada)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Antipsychotic; Dopamine; Estrogen; Hippocampus; MRI; Schizophrenia; Volumetric analysis

Indexed keywords

AMPHETAMINE; ESTRADIOL; HALOPERIDOL; CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; BASAL AMYGDALA; BRAIN SIZE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EXPOSURE; ESTROGEN THERAPY; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; INFRALIMBIC CORTEX; LONG TERM CARE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS SHELL; PRELIMBIC CORTEX; PRIORITY JOURNAL; RAT; REVIEW; SENSITIZATION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; THALAMOCORTICAL TRACT; TREATMENT RESPONSE; VENTRAL PALLIDUM; WAKEFULNESS; ANALYSIS OF VARIANCE; ANATOMY AND HISTOLOGY; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECTS; IMAGE PROCESSING; NEUROIMAGING; SPRAGUE DAWLEY RAT;

RATTUS;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALOPERIDOL; IMAGE PROCESSING, COMPUTER-ASSISTED; NEUROIMAGING; RATS; RATS, SPRAGUE-DAWLEY; WAKEFULNESS;

EID: 84938151552     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.05.025     Document Type: Article

References (47)

1. S. Akhondzadeh, A.A. Nejatisafa, H. Amini, M.R. Mohammadi, B. Larijani, L. Kashani, F. Raisi, and A. Kamalipour Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 1007 1012
2. A. Almey, N.M. Hafez, A. Hantson, and W.G. Brake Deficits in latent inhibition induced by estradiol replacement are ameliorated by haloperidol treatment Front. Behav. Neurosci. 7 2013 136
3. M.C. Angermeyer, and L. Kuhn Gender differences in age at onset of schizophrenia. An overview Eur. Arch. Psychiatry Neurol. Sci. 237 1988 351 364
4. A. Barros-Loscertales, H. Garavan, J.C. Bustamante, N. Ventura-Campos, J.J. Llopis, V. Belloch, M.A. Parcet, and C. Avila Reduced striatal volume in cocaine-dependent patients Neuroimage 56 2011 1021 1026
5. G. Bartzokis, M. Beckson, P.H. Lu, N. Edwards, R. Rapoport, E. Wiseman, and P. Bridge Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research Psychiatry Res. 98 2000 93 102
6. L. Becerra, P.C. Chang, J. Bishop, and D. Borsook CNS activation maps in awake rats exposed to thermal stimuli to the dorsum of the hindpaw Neuroimage 54 2011 1355 1366
7. J.B. Becker, H. Molenda, and D.L. Hummer Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse Ann. N. Y. Acad. Sci. 937 2001 172 187
8. C. Behl, R. Rupprecht, T. Skutella, and F. Holsboer Haloperidol-induced cell death - mechanism and protection with vitamin E in vitro Neuroreport 7 1995 360 364
9. S. Berman, J. O'Neill, S. Fears, G. Bartzokis, and E.D. London Abuse of amphetamines and structural abnormalities in the brain Ann. N. Y. Acad. Sci. 1141 2008 195 220
10. L. Chang, L.M. Smith, C. LoPresti, M.L. Yonekura, J. Kuo, I. Walot, and T. Ernst Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure Psychiatry Res. 132 2004 95 106
11. C.L. Chin, A.E. Tovcimak, V.P. Hradil, T.R. Seifert, P.R. Hollingsworth, P. Chandran, C.Z. Zhu, D. Gauvin, M. Pai, J. Wetter, G.C. Hsieh, P. Honore, J.M. Frost, M.J. Dart, M.D. Meyer, B.B. Yao, B.F. Cox, and G.B. Fox Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI Br. J. Pharmacol. 153 2008 367 379
12. H.S. Crombag, G. Gorny, Y. Li, B. Kolb, and T.E. Robinson Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex Cereb. Cortex 15 2005 341 348
13. K.A. Dorph-Petersen, J.N. Pierri, J.M. Perel, Z. Sun, A.R. Sampson, and D.A. Lewis The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys Neuropsychopharmacology 30 2005 1649 1661
14. R.E. Featherstone, S. Kapur, and P.J. Fletcher The amphetamine-induced sensitized state as a model of schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 1556 1571
15. M.L. Forgie, and J. Stewart Effect of prepubertal ovariectomy on amphetamine-induced locomotor activity in adult female rats Horm. Behav. 28 1994 241 260
16. T.R. Franklin, P.D. Acton, J.A. Maldjian, J.D. Gray, J.R. Croft, C.A. Dackis, C.P. O'Brien, and A.R. Childress Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients Biol. Psychiatry 51 2002 134 142
17. F. Guillem, A. Mendrek, M.E. Lavoie, T. Pampoulova, and E. Stip Sex differences in memory processing in schizophrenia: an event-related potential (ERP) study Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1 10
18. H. Hafner, S. Behrens, J. De Vry, and W.F. Gattaz An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia Psychiatry Res. 38 1991 125 134
19. H. Hafner Gender differences in schizophrenia Psychoneuroendocrinology 28 Suppl. 2 2003 S17 S54
20. J.D. Hallonquist, M.V. Seeman, M. Lang, and N.A. Rector Variation in symptom severity over the menstrual cycle of schizophrenics Biol. Psychiatry 33 1993 207 209
21. J.A. Jimenez, A. Mancini-Marie, N. Lakis, M. Rinaldi, and A. Mendrek Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia Schizophr. Res. 122 2010 53 62
22. P.W. Kalivas, and J. Stewart Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity Brain Res. Rev. 16 1991 223 244
23. S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia Am. J. Psychiatry 157 2000 514 520
24. G.T. Konopaske, K.A. Dorph-Petersen, J.N. Pierri, Q. Wu, A.R. Sampson, and D.A. Lewis Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys Neuropsychopharmacology 32 2007 1216 1223
25. G.T. Konopaske, K.A. Dorph-Petersen, R.A. Sweet, J.N. Pierri, W. Zhang, A.R. Sampson, and D.A. Lewis Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys Biol. Psychiatry 63 2008 759 765
26. J. Kulkarni, A. Riedel, A.R. de Castella, P.B. Fitzgerald, T.J. Rolfe, J. Taffe, and H. Burger Estrogen - a potential treatment for schizophrenia Schizophr. Res. 48 2001 137 144
27. J. Kulkarni, A. de Castella, B. Headey, N. Marston, K. Sinclair, S. Lee, C. Gurvich, P.B. Fitzgerald, and H. Burger Estrogens and men with schizophrenia: is there a case for adjunctive therapy Schizophr. Res. 125 2011 278 283
28. J.A. Lieberman, G.D. Tollefson, C. Charles, R. Zipursky, T. Sharma, R.S. Kahn, R.S. Keefe, A.I. Green, R.E. Gur, J. McEvoy, D. Perkins, R.M. Hamer, H. Gu, M. Tohen, and H.S. Group Antipsychotic drug effects on brain morphology in first-episode psychosis Arch. Gen. Psychiatry 62 2005 361 370
29. O. Lipatova, D. Byrd, J.T. Green, and D.J. Toufexis Effects of continuous vs. cycling estrogen replacement on the acquisition, retention and expression of place- and response-learning in the open-field tower maze Neurobiol. Learn. Mem. 114 2014 81 89
30. D. Madularu, W.M. Shams, and W.G. Brake Estrogen potentiates the behavioral and nucleus accumbens dopamine response to continuous haloperidol treatment in female rats Eur. J. Neurosci. 39 2014 257 265
31. D. Madularu, J.R. Yee, W.M. Kenkel, K.A. Moore, P. Kulkarni, W.M. Shams, C.F. Ferris, and W.G. Brake Integration of neural networks activated by amphetamine in females with different estrogen levels: A functional imaging study in awake rats Psychoneuroendocrinology 56 2015 200 212
32. A. Mendrek, A. Mancini-Marie, C. Fahim, and E. Stip Sex differences in the cerebral function associated with processing of aversive stimuli by schizophrenia patients Aust. N. Z. J. Psychiatry 41 2007 136 141
33. J. Moncrieff, and J. Leo A systematic review of the effects of antipsychotic drugs on brain volume Psychol. Med. 40 2010 1409 1422
34. J.G. Overpeck, S.H. Colson, J.R. Hohmann, M.S. Applestine, and J.F. Reilly Concentrations of circulating steroids in normal prepubertal and adult male and female humans, chimpanzees, rhesus monkeys, rats, mice, and hamsters: a literature survey J. Toxicol. Env. Health 4 1978 785 803
35. L.R. Qiu, J. Germann, S. Spring, C. Alm, D.A. Vousden, M.R. Palmert, and J.P. Lerch Hippocampal volumes differ across the mouse estrous cycle, can change within 24 h, and associate with cognitive strategies Neuroimage 83 2013 593 598
36. M.G. Quinlan, D. Hussain, and W.G. Brake Use of cognitive strategies in rats: the role of estradiol and its interaction with dopamine Horm. Behav. 53 2008 185 191
37. A. Riecher-Rossler, H. Hafner, M. Stumbaum, K. Maurer, and R. Schmidt Can estradiol modulate schizophrenic symptomatology Schizophr. Bull. 20 1994 203 214
38. T.E. Robinson, and B. Kolb Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine J. Neurosci. 17 1997 8491 8497
39. T.E. Robinson, and B. Kolb Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine Eur. J. Neurosci. 11 1999 1598 1604
40. A.N. Samaha, P. Seeman, J. Stewart, H. Rajabi, and S. Kapur "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time J. Neurosci. 27 2007 2979 2986
41. A.N. Samaha, G.E. Reckless, P. Seeman, M. Diwan, J.N. Nobrega, and S. Kapur Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery Biol. Psychiatry 64 2008 145 152
42. Sarvari, M., Deli, L., Kocsis, P., Mark, L., Maasz, G., Hrabovszky, E., Kallo, I., Gajari, D., Vastagh, C., Sumegi, B., Tihanyi, K., Liposits, Z., 2014. Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats. Brain Res.
43. W.J. Schmidt, and R.J. Beninger Behavioral sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia Neurotoxic. Res. 10 2006 161 166
44. M.E. Sim, I.K. Lyoo, C.C. Streeter, J. Covell, O. Sarid-Segal, D.A. Ciraulo, M.J. Kim, M.J. Kaufman, D.A. Yurgelun-Todd, and P.F. Renshaw Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects Neuropsychopharmacology 32 2007 2229 2237
45. P. Vezina D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area J. Neurosci. 16 1996 2411 2420
46. P. Vezina, and A.L. Queen Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area Psychopharmacology 151 2000 184 191
47. C.S. Woolley, and B.S. McEwen Estradiol regulates hippocampal dendritic spine density via an N-methyl-d-aspartate receptor-dependent mechanism J. Neurosci. 14 1994 7680 7687